Dr. Bahng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18625 Sherman Way
Reseda, CA 91335Phone+1 818-342-8171
Education & Training
- Kaiser Permanente Southern California (Inland Empire)Residency, Internal Medicine, 2013 - 2016
- New York-Presbyterian/QueensInternship, Internal Medicine, 2011 - 2012
- Lewis Katz School of Medicine at Temple UniversityClass of 2011
Certifications & Licensure
- CA State Medical License 2014 - 2026
Publications & Presentations
PubMed
- 83 citationsDichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.Edward B. Garon, Heather R. Christofk, Wylie Hosmer, Carolyn D. Britten, Agnes Bahng
Journal of Cancer Research and Clinical Oncology. 2014-01-18 - 60 citationsDetermination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.Agnes Y. Bahng, Avner Dagan, Deborah Watkins Bruner, Lilie L. Lin
International Journal of Radiation Oncology, Biology, Physics. 2012-02-01 - 8 citationsRisk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma.Agnes Y. Bahng, Christina S. Chu, Paul Wileyto, Stephen C. Rubin, Lilie L. Lin
Journal of Gynecologic Oncology. 2012-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: